Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study
Fuente:
Redalyc
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Instituto Nacional de Salud
2023
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1876427109376720896 |
|---|---|
| author | Gloria Mercedes Puerto |
| author_facet | Gloria Mercedes Puerto |
| contents | Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study Gloria Mercedes Puerto Claudia Marcela Castro Vivian Vanesa Rubio Santiago Fadul Fernando Montes Medicina case multiple Tuberculosis black people risk factors Introduction. Multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is difficult to control, has high morbidity and mortality, and demands priority public health intervention. In Colombia, MDR/RR-TB has been becoming more widespread annually. Before the COVID-19 pandemic, over an 8-year period, the number of cases of multidrug-resistant tuberculosis in Colombia was close to a thousand cases. Timely identification of the different risk factors for MDR/RR-TB will contribute fundamentally to the systematic management.Objective. To determine which risk factors were associated with the presentation of MDR in Colombia between 2013 and 2018.Materials and methods. A retrospective case-control study was carried out, for which the data from the routine surveillance of MDR/events in the country were used.Results. The cases of multidrug-resistant tuberculosis were mainly in young people, Afrodescendants, and males. Of the clinical conditions, comorbidities such as malnutrition, diabetes, and HIV, presence of at least one factor, such as drug dependence, taking immunosuppressive medications, belonging to the black race, afro, and living in an area of high disease burden were risk factors.Conclusion. In addition to the diagnosis and timely provision of MDR-TB treatment, it is necessary that public health programs at the local level pay special attention to patients with the identified risk factors. 2023 artículo científico 0120-4157 https://www.redalyc.org/articulo.oa?id=84376574004 https://www.redalyc.org/journal/843/84376574004/ https://www.redalyc.org/journal/843/84376574004/html/ https://www.redalyc.org/journal/843/84376574004/84376574004.epub https://www.redalyc.org/journal/843/84376574004/movil https://doi.org/10.7705/biomedica.6842 en http://www.redalyc.org/revista.oa?id=843 Biomédica application/pdf Instituto Nacional de Salud Biomédica (Colombia) Num.4 Vol.43 |
| format | Artículo científico |
| id | redalyc_84376574004 |
| institution | Redalyc |
| language | en |
| publishDate | 2023 |
| publisher | Instituto Nacional de Salud |
| spellingShingle | Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study Gloria Mercedes Puerto Medicina case multiple Tuberculosis black people risk factors Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study Gloria Mercedes Puerto Claudia Marcela Castro Vivian Vanesa Rubio Santiago Fadul Fernando Montes Medicina case multiple Tuberculosis black people risk factors Introduction. Multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is difficult to control, has high morbidity and mortality, and demands priority public health intervention. In Colombia, MDR/RR-TB has been becoming more widespread annually. Before the COVID-19 pandemic, over an 8-year period, the number of cases of multidrug-resistant tuberculosis in Colombia was close to a thousand cases. Timely identification of the different risk factors for MDR/RR-TB will contribute fundamentally to the systematic management.Objective. To determine which risk factors were associated with the presentation of MDR in Colombia between 2013 and 2018.Materials and methods. A retrospective case-control study was carried out, for which the data from the routine surveillance of MDR/events in the country were used.Results. The cases of multidrug-resistant tuberculosis were mainly in young people, Afrodescendants, and males. Of the clinical conditions, comorbidities such as malnutrition, diabetes, and HIV, presence of at least one factor, such as drug dependence, taking immunosuppressive medications, belonging to the black race, afro, and living in an area of high disease burden were risk factors.Conclusion. In addition to the diagnosis and timely provision of MDR-TB treatment, it is necessary that public health programs at the local level pay special attention to patients with the identified risk factors. 2023 artículo científico 0120-4157 https://www.redalyc.org/articulo.oa?id=84376574004 https://www.redalyc.org/journal/843/84376574004/ https://www.redalyc.org/journal/843/84376574004/html/ https://www.redalyc.org/journal/843/84376574004/84376574004.epub https://www.redalyc.org/journal/843/84376574004/movil https://doi.org/10.7705/biomedica.6842 en http://www.redalyc.org/revista.oa?id=843 Biomédica application/pdf Instituto Nacional de Salud Biomédica (Colombia) Num.4 Vol.43 |
| title | Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study |
| topic | Medicina case multiple Tuberculosis black people risk factors |
| url | https://www.redalyc.org/articulo.oa?id=84376574004 https://www.redalyc.org/journal/843/84376574004/ https://www.redalyc.org/journal/843/84376574004/html/ https://www.redalyc.org/journal/843/84376574004/84376574004.epub https://www.redalyc.org/journal/843/84376574004/movil https://doi.org/10.7705/biomedica.6842 |